Clinical Trial Update: Study of Escitalopram in Adult Patients With Major Depressive Disorder [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating escitalopram for major depressive disorder in adults has completed. The sponsor is Forest Laboratories.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Escitalopram (escitalopram)

Snippet

Sponsor: Forest Laboratories | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED